Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 11, 2019
TickeronGET DAILY SIGNALS
Weight Watchers (WW, $22.95) stock gets a rating upgrade and a higher price target by JP Morgan analysts

Weight Watchers (WW, $22.95) stock gets a rating upgrade and a higher price target by JP Morgan analysts

Shares of Weight Watchers International Inc. jumped more than +5% on Thursday, as JP Morgan analysts softened their bearish stance on the stock.

 J.P. Morgan analyst Christina Brathwaite upgraded the stock's rating to neutral from underweight. She also raised her price target to $22 from $17 a share.

Brathwaite indicated that she was no longer bearish on the weight management & fitness company, citing stabilizing subscriber trends and the potential growth opportunity in 2020 following the launch of a new diet program by the company at the end of this year.

Related Ticker: WW

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for WW turns negative, indicating new downward trend

WW saw its Momentum Indicator move below the 0 level on November 03, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned negative. In 83 of the 89 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for WW turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 41 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for WW entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 62 of 70 cases where WW's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.

Following a +18.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where WW advanced for three days, in 210 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

WW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 11 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. WW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.406) is normal, around the industry mean (204.532). P/E Ratio (0.827) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (5.307) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.167) is also within normal values, averaging (2.688).

The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 5.37B. The market cap for tickers in the group ranges from 20.9K to 107.17B. HCA holds the highest valuation in this group at 107.17B. The lowest valued company is NMMCF at 20.9K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -3%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 8%. GRDN experienced the highest price growth at 24%, while BMGL experienced the biggest fall at -89%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was -18%. For the same stocks of the Industry, the average monthly volume growth was 63% and the average quarterly volume growth was -55%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 46
Price Growth Rating: 53
SMR Rating: 66
Profit Risk Rating: 82
Seasonality Score: -6 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of weight management services

Industry HospitalNursingManagement

Industry
Other Consumer Services
Address
18 West 18th Street
Phone
+1 212 589-2700
Employees
3500
Web
https://corporate.ww.com
Interact to see
Advertisement
BZ dropped sharply, sliding from a $16.72 prior close to $13.48 (-19.38%), with the decline beginning in premarket and deepening into the early regular session. No verified company-specific news or fundamental catalyst was issued; the fall tracked a broad China ADR selloff (the Nasdaq Golden Dragon index slid more than 2%), but that alone is too small to explain a ~20% drop — the stock's Hong Kong listing fell only -2.6%.
NBIS fell from $154.69 to $129.12, down -16.53%, with the decline starting in premarket trading and continuing through the regular session. The drop followed Q3 results: revenue of $980.8M (+571% YoY) beat estimates, but management cut 2026 revenue guidance to the low end of its range on third-party capacity delays and raised 2026 capex to roughly $27B, reviving financing and execution fears.
The $1.14 central target is not an analyst consensus; it is the all-cash merger consideration in GoPro, Inc. (GPRO) 's pending deal with Starman Optical, agreed in September 2026. With the stock trading near $0.88, reaching $1.14 would require a move of roughly 29.5%.
The central target of $21 is the arithmetic mean of three recently attributable analyst price targets on RUM — $25 (Lake Street), $15 (Texas Capital), and $22 (Maxim Group) — which average roughly $20.67. With shares trading near $5.90 after a post-earnings surge, reaching $21 would require a gain of roughly 256%, a very large move.
The $1 target in this article is not an analyst price target; it is the $1.00 Nasdaq minimum bid price requirement, the level Cenntro itself has publicly targeted through a 1-for-60 reverse stock split. Cenntro trades near $0.12 per share, meaning reaching $1 would require an increase of roughly 730%—an exceptionally large move.